Detailed View
ZVRA - Zevra Therapeutics, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
593,243,968
Adj EBIT (TTM)
95,510,000
Enterprise Value
447,922,968
Last Price
9.99
Earnings Yield
21.32%
Return on Capital
39.21%
Capital
243,590,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 39,663,000 | 16,777,000 |
| 2026-03-31 | 10-Q | 2026 | 36,200,000 | 52,146,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 34,155,000 | 9,315,000 |
| 2025-09-30 | 10-Q | 2025 | 26,063,000 | 4,143,000 |
| 2025-06-30 | 10-Q | 2025 | 25,881,000 | -71,039,000 |
| 2025-03-31 | 10-Q | 2025 | 20,401,000 | -5,362,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 8,618,000 | -15,416,000 |
| 2024-09-30 | 10-Q | 2024 | 3,695,000 | -27,306,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.